Meeting News Coverage

Dapagliflozin, potassium-sparing diuretics lower HbA1c in type 2 diabetes

October 19, 2016
NEW ORLEANS — The use of dapagliflozin in combination with potassium-sparing diuretics significantly lowered HbA1c, body weight and systolic…
Meeting News CoverageVideo

VIDEO: Empagliflozin significantly reduces microvascular outcomes

September 16, 2016
NEW ORLEANS — Empagliflozin, an SGLT2 inhibitor, used in addition to standard of care reduced the risk for composite microvascular outcomes in…
Meeting News Coverage

Semaglutide improves glycemic control in type 2 diabetes

September 15, 2016
NEW ORLEANS — Once-weekly semaglutide appears superior to exenatide extended-release in improving HbA1c and reducing body weight in subjects…
Meeting News CoverageVideo

VIDEO: Possible mechanism for why empagliflozin improves cardiovascular outcomes identified

September 9, 2016
Michael T. McDermott, MD, director of endocrinology and diabetes practice at the University of Colorado Hospital, discusses ‘very…
Meeting News Coverage

Canagliflozin demonstrates improved glycemic control in type 2 diabetes

September 7, 2016
NEW ORLEANS — Patients with type 2 diabetes treated with canagliflozin in a real-world setting achieved a greater reduction in HbA1c compared…
Meeting News CoverageVideo

VIDEO: Physicians must clearly inform patients with diabetes about risks for ketoacidosis when using SGLT2 inhibitors

September 5, 2016
NEW ORLEANS — Patients with diabetes who test urine ketones may miss a diagnosis of ketoacidosis because of the particular effects SGLT2…
Meeting News CoverageVideo

VIDEO: Investigational therapy appears non-inferior to classic insulin in treating type 1 diabetes

September 2, 2016
NEW ORLEANS — The use of MK-1293 – an investigational biosimilar insulin glargine – produced a similar efficacy and safety profile…
Meeting News CoverageVideo

VIDEO: Results of LEADER trial may have ‘huge impact’ on patients with diabetes

August 26, 2016
Results of the LEADER trial demonstrated that treatment with liraglutide compared with placebo in patients with type 2 diabetes not only decreased…
Meeting News Coverage

Insulin glargine, detemir effective in treating inpatient hyperglycemia

August 24, 2016
NEW ORLEANS — Insulin detemir and insulin glargine were found to be equally effective in managing patients with diabetes, with no significant…
Meeting News Coverage

Liraglutide, metformin combination reduces risk for diabetes in postpartum women

August 19, 2016
NEW ORLEANS — The addition of liraglutide to metformin led to greater weight loss and improvements in insulin secretion and action in women who…